Bausch Health Companies (BHC) Total Current Liabilities (2009 - 2026)
Bausch Health Companies (BHC) reported Total Current Liabilities of $4.5 billion for Q1 2026, up 6.44% on a YoY basis from $4.3 billion in Q1 2025, and up 8.37% sequentially from $4.2 billion in Q4 2025.
Bausch Health Companies (BHC) Total Current Liabilities (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Total Current Liabilities data on file, last reported at $4.5 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 6.44% year-over-year to $4.5 billion; the trailing twelve-month figure through Mar 2026 stood at $4.5 billion (up 6.44% YoY), and the FY2025 full-year result was $4.2 billion, down 38.09% from the prior year.
- Total Current Liabilities improved to $4.5 billion in Q1 2026, from $4.2 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $6.8 billion in Q4 2024 to a low of $3.8 billion in Q3 2022.
- A 5-year average of $4.5 billion and a median of $4.4 billion in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities surged 56.95% in 2024 and tumbled 38.09% in 2025, its largest moves.
- Tracing BHC's Total Current Liabilities over 5 years: stood at $3.9 billion in 2022, then grew by 9.16% to $4.3 billion in 2023, then surged by 56.95% to $6.8 billion in 2024, then plunged by 38.09% to $4.2 billion in 2025, then increased by 8.37% to $4.5 billion in 2026.
- Business Quant data shows BHC's Total Current Liabilities at $4.5 billion in Q1 2026, $4.2 billion in Q4 2025, and $4.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 4.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.53 Bn |
| Dec 31, 2025 | 4.18 Bn |
| Sep 30, 2025 | 4.79 Bn |
| Jun 30, 2025 | 4.98 Bn |
| Mar 31, 2025 | 4.26 Bn |
| Dec 31, 2024 | 6.75 Bn |
| Sep 30, 2024 | 4.51 Bn |
| Jun 30, 2024 | 4.37 Bn |
| Mar 31, 2024 | 4.41 Bn |
| Dec 31, 2023 | 4.30 Bn |
| Sep 30, 2023 | 4.22 Bn |
| Jun 30, 2023 | 3.97 Bn |
| Mar 31, 2023 | 3.92 Bn |
| Dec 31, 2022 | 3.94 Bn |
| Sep 30, 2022 | 3.83 Bn |
| Jun 30, 2022 | 5.00 Bn |
| Mar 31, 2022 | 4.77 Bn |
| Dec 31, 2021 | 5.20 Bn |
| Sep 30, 2021 | 5.44 Bn |
| Jun 30, 2021 | 5.52 Bn |